A Phase 2a Study to Evaluate the Safety and Tolerability of MEDI-563 in Adults With Asthma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00783289
First received: October 30, 2008
Last updated: August 20, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 28, 2012